SCHEMBL1084145

SCHEMBL1084145

COc1ccc(F)cc1-c1nc(N(C)C)c2ccccc2n1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 14/20 0.81
CYP2D6 P10635 13/20 0.81
CYP3A4 P08684 11/20 0.81
TSHR P16473 10/20 0.81
LMNA P02545 8/20 0.81
USP2 O75604 7/20 0.81
HSD17B10 Q99714 7/20 0.81
ALDH1A1 P00352 6/20 0.81
ALOX15 P16050 5/20 0.81
TP53 P04637 2/20 0.81
CYP2C19 P33261 8/20 0.54
CLK4 Q9HAZ1 6/20 0.54
MAPK1 P28482 5/20 0.54
CYP2C9 P11712 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.51
KDM4E B2RXH2 2/20 0.51
ABCG2 Q9UNQ0 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 4/20 0.49
HIF1A Q16665 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938193 0.90 CYP1A2 (1.00) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL939163 0.86 CYP2D6 (0.74) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1084346 0.86 LMNA (0.59) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1083943 0.85 CYP2D6 (0.72) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL938570 0.85 CYP2D6 (0.72) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1084479 0.84 CYP2D6 (0.63) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL2327438 0.82 CYP1A2 (0.53) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1084218 0.82 CYP2D6 (0.60) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1083778 0.82 CYP2D6 (0.63) CYP1A2CYP2D6CYP3A4TSHRLMNA
SCHEMBL1084265 0.81 CYP2D6 (0.61) CYP1A2CYP2D6CYP3A4TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed